Drug Trial Radar · NCT02365493
Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection
Last checked: Nov 19, 2026Latest source record: Dec 19, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
358
Actual
Start
Aug 26, 2015
Primary completion
Oct 24, 2018
Study completion Oct 24, 2018
Sponsor
- Lead sponsor
- Menzies School of Health ResearchAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Australasian Society for Infectious Diseases; Singapore Infectious Diseases Clinical Research Network; The University of Queensland; Australasian Kidney Trials Network
- First posted
- Feb 19, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this clinical trial is to determine whether a novel combination antibiotic treatment (vancomycin/daptomycin + beta-lactam) is superior to the standard antibiotic treatment (vancomycin/daptomycin) for hospitalised adults with Methicillin Resistant Staphylococcus aureus bacteraemia. The hypothesis is that the addition of beta-lactam antibiotics (these are antibiotics from the penicillin family) to the standard therapy will lead to more efficient bacterial killing and hence lead to faster clearance of bacteria from the blood stream and other areas of infection, thereby reducing the risk of the spread of infection and death. The study design is an investigator-initiated, multi-centre, open-label, randomised controlled trial. This will include 440 participants diagnosed with Methicillin Resistant Staphylococcus aureus bacteraemia recruited over a period of 4 years (July 2015 - June 2019) from within Infectious Diseases inpatient units across 21 hospital sites including 18 from within Australia and 3 located in Singapore. Participation will be voluntary and subject to informed consent. The participants will be randomised 1:1 to either the standard therapy group or combination therapy group. The combination therapy will include a treatment of intravenous beta-lactam for the first 7 days of treatment, in addition to the standard treatment (either vancomycin or daptomycin). The primary outcome measure will be complication-free survival 90 days post randomisation.
Conditions
- Methicillin-Resistant Staphylococcus Aureus
Interventions
Beta-LactamDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complication-free 90 day survivalTime frame: Time period from randomisation (day 1) to day 90
Locations
30 sites in 4 countries. Site status is shown where the registry gives one.
Blacktown Hospital
Blacktown, New South Wales, Australia
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Concord Repatriation General Hospital
Concord, New South Wales, Australia
St Vincent's Hospital
Darlinghurst, New South Wales, Australia
Nepean Hospital
Kingswood, New South Wales, Australia
Liverpool Hospital
Liverpool, New South Wales, Australia
John Hunter Hospital
New Lambton Heights, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
Wollongong Hospital
Wollongong, New South Wales, Australia
Royal Darwin Hospital
Darwin, Northern Territory, Australia
Cairns Hospital
Cairns, Queensland, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Flinder's Medical Centre
Bedford Park, South Australia, Australia
The Queen Elizabeth Hospital
Woodville South, South Australia, Australia
Monash Medical Centre Clayton Campus
Clayton, Victoria, Australia
Dandenong Hospital
Dandenong, Victoria, Australia
Western Health - Footscray
Footscray, Victoria, Australia
Austin Hospital
Heidelberg, Victoria, Australia
Western Health - Sunshine Hospital
Sunshine, Victoria, Australia
Western Health - Williamstown Hospital
Williamstown, Victoria, Australia
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Royal Perth Hospital
Perth, Western Australia, Australia
Rambam Health Corporation
Haifa, Israel
Beilinson Hospital
Petah Tikva, Israel
Middlemore Hospital
Otahuhu, Auckland, New Zealand
National University Hospital
Kent Ridge, Singapore
Singapore General Hospital
Outram Park, Singapore
Tan Tock Seng Hospital
Novena, Tan Tock Seng, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.